Lord, Abbett & Co
BSX.PRA

Lord, Abbett & Co’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Lord, Abbett & Co’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$29M Buy
2022
Q4 		$23.8M Buy
2022
Q3 		$10.3M Sell
2022
Q2 		$10.7M Buy
2022
Q1 		$8.59M Buy
2020
Q4 		– Sell
2020
Q3 		$18.6M Sell
2020
Q2 		$17.4M Buy